Skip to main content

Advertisement

Open Peer Review Reports for: A phase I, randomized, observer-blinded, single and multiple ascending-dose study to investigate the safety, pharmacokinetics, and immunogenicity of BITS7201A, a bispecific antibody targeting IL-13 and IL-17, in healthy volunteers

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
28 Aug 2018 Submitted Original manuscript
18 Oct 2018 Reviewed Reviewer Report - Peter Lichtlen
23 Oct 2018 Reviewed Reviewer Report - Qi Zhao
19 Nov 2018 Author responded Author comments - Tracy L Staton
Resubmission - Version 2
19 Nov 2018 Submitted Manuscript version 2
23 Nov 2018 Reviewed Reviewer Report - Peter Lichtlen
30 Nov 2018 Author responded Author comments - Tracy L Staton
Resubmission - Version 3
30 Nov 2018 Submitted Manuscript version 3
Publishing
10 Dec 2018 Editorially accepted
7 Jan 2019 Article published 10.1186/s12890-018-0763-9

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement